SUBSCRIBE
SUBSCRIBE

BioSig Technologies

NEWS
Drug Development
Clinical Catch-Up: April 12-16
It was a particularly busy week for clinical trial news, in part because of several big medical conferences. Here’s a look.
April 16, 2021
 · 
12 min read
 · 
Mark Terry
Drug Development
Biopharma Update on the Novel Coronavirus: June 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 22, 2020.
June 22, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: June 5
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 5, 2020.
June 5, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
BioForest
Clinical Catch-Up: May 18-22
Non-COVID-19 clinical trial updates are outweighing COVID-19 studies, particularly with the American Society of Clinical Oncology meeting coming up soon. Here’s a look.
May 22, 2020
 · 
9 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: May 4
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 4, 2020.
May 4, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Pharm Country
Clinical Catch-Up: April 13-17
There’s plenty of news related to clinical trials related to COVID-19, but it does seem to be drowning out non-COVID-19-related clinical trials. Here’s a look.
April 17, 2020
 · 
11 min read
 · 
Mark Terry
Drug Development
Biopharma Update on the Novel Coronavirus: April 16
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.
April 16, 2020
 · 
8 min read
 · 
BioSpace Editorial Staff
A Day in the Life of BioSig CEO Greg Cash
Business
Day in the Life of a CEO—Greg Cash, BioSig Technologies
May 18, 2015
 · 
5 min read
Job Trends
BioSig Technologies Will Hire a Dozen As it Moves HQ to Minnesota, CEO Tells BioSpace
April 14, 2015
 · 
2 min read
JOBS
IN THE PRESS
Press Releases
BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
November 14, 2024
 · 
3 min read
Press Releases
BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel
October 23, 2024
 · 
3 min read
Press Releases
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
August 1, 2024
 · 
14 min read
Press Releases
BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024
July 26, 2024
 · 
3 min read
Deals
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 30, 2024
 · 
5 min read
Deals
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 30, 2024
 · 
6 min read
Business
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent
May 3, 2024
 · 
9 min read
Business
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
April 30, 2024
 · 
5 min read
Pharm Country
BioSig Engages Consulting Firm for Business Model Strategies BAIPC will work to deploy a series of solutions to transform BioSig’s future course
April 4, 2024
 · 
3 min read
Business
BioSig Announces Reduction of its Workforce
February 20, 2024
 · 
2 min read
Load More